
Ask a doctor about a prescription for TOPIRAMATE PENSA PHARMA 50 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Topiramate Pensa Pharma 50 mg film-coated tablets
This medicinal product is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of this leaflet includes information on how to report side effects.
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the pack and other information
Topiramate Pensa Pharma belongs to a group of medicines called antiepileptic medicines. It is used to:
Do not take Topiramate Pensa Pharma
Make sure to read the patient guide that you will receive from your doctor.
A patient card is provided with the packaging of Topiramate Pensa Pharma to remind you of the risks during pregnancy.
If you are not sure if any of the above applies to you, consult your doctor or pharmacist before taking Topiramate Pensa Pharma.
Warnings and precautions
Consult your doctor before taking Topiramate Pensa Pharma if you:
If you are not sure if any of the above applies to you, consult your doctor or pharmacist before taking Topiramate Pensa Pharma.
If you have epilepsy, it is important not to stop taking your medication without consulting your doctor first.
It is important that you do not stop taking your medication without consulting your doctor first.
You should consult your doctor before taking any other medicine containing topiramate that is given to you as an alternative to Topiramate Pensa Pharma.
You may lose weight if you take Topiramate Pensa Pharma, so your weight should be checked regularly while you are taking this medicine. If you lose too much weight or if a child taking this medicine does not gain enough weight, you should consult your doctor.
A small number of people being treated with antiepileptic drugs such as Topiramate Pensa Pharma have had thoughts of harming or killing themselves. If at any time you have these thoughts, contact your doctor immediately.
Topiramate Pensa Pharma may rarely cause high levels of ammonia in the blood (seen in blood tests), which can cause a change in brain function, especially if you are also taking a medicine called valproic acid or sodium valproate. Since this can be a serious disease, talk to your doctor immediately if you experience any of the following symptoms (see also section 4 “Possible side effects”):
Taking higher doses of Topiramate Pensa Pharma may increase the risk of developing these symptoms.
Other medicines and Topiramate Pensa Pharma
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. Topiramate Pensa Pharma and certain medicines can affect each other. Sometimes the dose of one of the other medicines or Topiramate Pensa Pharma may need to be adjusted.
In particular, tell your doctor or pharmacist if you are taking:
Tell your doctor if your menstrual bleeding changes while you are taking hormonal contraceptives and Topiramate Pensa Pharma. You may experience irregular bleeding. In this case, keep taking your hormonal contraceptives and consult your doctor.
Keep a list of all the medicines you take. Show this list to your doctor and pharmacist before you start taking a new medicine.
Other medicines that you should tell your doctor or pharmacist about include other antiepileptic medicines, risperidone, lithium, hydrochlorothiazide, metformin, pioglitazone, gliburide, amitriptyline, propranolol, diltiazem, venlafaxine, flunarizine, St. John's Wort (Hypericum perforatum) (a herbal preparation used to treat depression).
If you are not sure if any of the above applies to you, consult your doctor or pharmacist before taking Topiramate Pensa Pharma.
Taking Topiramate Pensa Pharma with food and drinks
You can take Topiramate Pensa Pharma with or without food. Drink plenty of fluids during the day to prevent the formation of kidney stones while taking Topiramate Pensa Pharma. You should avoid drinking alcohol while taking Topiramate Pensa Pharma.
Pregnancy and breastfeeding
Important advice for women of childbearing potential:
Topiramate Pensa Pharma may harm an unborn baby during pregnancy. If you are a woman of childbearing potential, consult your doctor about other possible treatments. Visit your doctor to review your treatment and discuss the risks at least once a year.
Migraine prevention:
Epilepsy treatment:
The risks of topiramate when taken during pregnancy (regardless of the condition for which topiramate is used) are as follows:
There is a risk of harm to the unborn baby during pregnancy if Topiramate Pensa Pharma is used during pregnancy.
Need for contraceptive methods for women of childbearing potential:
Use of Topiramate Pensa Pharma in girls:
If you are the parent or caregiver of a girl treated with Topiramate Pensa Pharma, you should consult your doctor immediately once your daughter experiences her first menstrual period (menarche). The doctor will inform you about the risks to an unborn baby during pregnancy due to exposure to topiramate during pregnancy and about the need for highly effective contraceptive methods.
If you wish to become pregnant while taking Topiramate Pensa Pharma:
If you become pregnant or think you may be pregnant while taking Topiramate Pensa Pharma:
Make sure to read the patient guide that you will receive from your doctor. A patient card is provided with the packaging of Topiramate Pensa Pharma to remind you of the risks during pregnancy.
Breastfeeding
The active substance of Topiramate Pensa Pharma (topiramate) passes into breast milk. Effects have been seen in breastfed babies of mothers treated with topiramate, including diarrhea, drowsiness, irritability, and low weight gain. Therefore, your doctor will discuss with you whether to stop breastfeeding or stop treatment with Topiramate Pensa Pharma. Your doctor will take into account the benefits for the mother and the risk for the baby.
Breastfeeding mothers taking Topiramate Pensa Pharma should inform their doctor as soon as possible if the baby experiences anything unusual.
Driving and using machines
Dizziness, tiredness, and vision disturbances may occur during treatment with Topiramate Pensa Pharma. Do not drive or operate tools or machines without talking to your doctor first.
Topiramate Pensa Pharma contains soy lecithin
Topiramate Pensa Pharma contains soy lecithin derived from soybean oil. It should not be used in case of peanut or soy allergy.
Follow the administration instructions of this medication exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Girls and women of childbearing age:
Treatment with Topiramato Pensa Pharma should begin and continue under the supervision of a doctor with experience in the treatment of epilepsy or migraine. Visit your doctor to review your treatment at least once a year.
If you take more Topiramato Pensa Pharma than you should:
Consult your doctor immediately. Bring the medication with you.
You may feel drowsy, tired, or less attentive, lack of coordination, have difficulty speaking or concentrating; have double or blurred vision; feel dizzy due to a drop in blood pressure; feel depressed or restless; or have abdominal pain or seizures (attacks).
You may experience an overdose if you are taking another medication along with Topiramato Pensa Pharma.
In case of overdose or accidental ingestion, you can also consult the Toxicology Information Service, Phone: 91 562 04 20.
If you forget to take Topiramato Pensa Pharma
If you interrupt treatment with Topiramato Pensa Pharma
Do not interrupt treatment without your doctor telling you to do so. Your disease symptoms may reappear. If your doctor decides that you should stop taking this medication, they will gradually decrease your dose over several days.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medications, Topiramato Pensa Pharma can have adverse effects, although not all people experience them.
Consult your doctor or seek immediate medical attention if you have the following adverse effects:
Very Common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Other Adverse Effects Include the Following, if Severe, Please Consult Your Doctor or Pharmacist:
Very Common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Unknown (cannot be estimated from the available data)
Other Adverse Effects in Children
Generally, the adverse effects observed in children are similar to those observed in adults, but the following adverse effects may be more frequent in children than in adults:
Other adverse effects that may occur in children are:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Keep in the outer packaging to protect it from moisture.
Do not use Topiramato Pensa Pharma after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown away through drains or in the trash. Deposit the packaging and medications you no longer need in the SIGRE collection point at the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Topiramato Pensa Pharma
The active ingredient is topiramate.
Each Topiramato Pensa Pharma film-coated tablet contains 50 mg of topiramate.
The other components of Topiramato Pensa Pharma are listed below: mannitol, pregelatinized maize starch, microcrystalline cellulose, sodium croscarmellose, anhydrous colloidal silica, magnesium stearate, purified water. Coating: Polyvinyl alcohol, titanium dioxide (E-171), macrogol 3350, talc, soy lecithin (E-322), and yellow iron oxide (E-172).
Appearance of Topiramato Pensa Pharma and Package Contents
Topiramato Pensa Pharma 50 mg is presented in the form of film-coated tablets, round and light yellow in color.
It is presented in bottles containing 60 film-coated tablets.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer:
TOLL MANUFACTURING SERVICES, S.L.
C/ Aragoneses, 2
28108 Alcobendas (Madrid)
Spain
Date of the Last Revision of this Leaflet:April 2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) www.aemps.gob.es
Other Sources of Information
Approved patient information about this medication is available by scanning the following QR code with a smartphone. The same information is also available on the following website (URL): https://cima.aemps.es/cima/DocsPub/16/3252
[Insert QR code]
The average price of TOPIRAMATE PENSA PHARMA 50 mg FILM-COATED TABLETS in November, 2025 is around 18.31 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for TOPIRAMATE PENSA PHARMA 50 mg FILM-COATED TABLETS – subject to medical assessment and local rules.